Mobivity (MFON) 10-K 30 Mar 22 2021 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 30, 2022	Jun. 30, 2021
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Document Transition Report	false
Entity File Number	000-53851
Entity Registrant Name	Mobivity Holdings Corp.
Entity Incorporation, State Country Code	NV
Tax Identification Number (TIN)	26-3439095
Entity Address, Address Line One	3133 West Frye Road
Entity Address, Address Line Two	# 215
Entity Address, City or Town	Chandler
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85226
City Area Code	877
Local Phone Number	282-7660
Title of 12(g) Security	Common Stock, $.001 par value
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 26,270,789
Entity Common Stock, Shares Outstanding		58,573,885
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001447380
Amendment Flag	false
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Auditor Name	M&K CPAS, PLLC
Auditor Location	Houston, TX
Auditor Firm ID	2738

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash	$ 735,424	$ 3,282,820
Accounts receivable, net of allowance for doubtful accounts of $56,340 and $33,848, respectively	578,303	305,693
Contracts receivable, current		943,904
Other current assets	227,458	272,736
Total current assets	1,541,185	4,805,153
Goodwill	411,183	496,352
Right to use lease assets	1,187,537	57,482
Intangible assets, net	1,124,720	1,368,329
Contracts receivable, long term		1,415,856
Other assets	173,325	25,230
TOTAL ASSETS	4,437,950	8,168,402
Current liabilities
Accounts payable	3,823,909	1,935,411
Accrued interest	172,239	47,316
Accrued and deferred personnel compensation	495,533	224,881
Deferred revenue and customer deposits	377,170	606,597
Related party notes payable - net current maturities	819,531	80,000
Notes payable, net - current maturities	69,052	561,676
Operating lease liability	229,240	58,173
Other current liabilities	9,071	566,303
Total current liabilities	5,995,745	4,080,357
Non-current liabilities
Related party notes payable, net - long term	2,498,711	500,000
Notes payable, net - long term	39,086	999,001
Operating lease liability	1,188,589	13,296
Other long term liabilities		831,535
Total non-current liabilities	3,726,386	2,343,832
Total liabilities	9,722,131	6,424,189
Commitments and Contingencies (See Note 13)
Stockholders' equity (deficit)
Common stock, $0.001 par value; 100,000,000 shares authorized; 55,410,695 and 55,410,695, shares issued and outstanding	55,411	55,411
Equity payable	100,862	100,862
Additional paid-in capital	102,446,921	101,186,889
Accumulated other comprehensive income (loss)	(52,088)	(23,446)
Accumulated deficit	(107,835,287)	(99,575,503)
Total stockholders' equity (deficit)	(5,284,181)	1,744,213
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 4,437,950	$ 8,168,402

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Consolidated Balance Sheets [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 56,340	$ 33,848
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	55,410,695	55,410,695
Common stock, shares outstanding	55,410,695	55,410,695

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenues
Revenues	$ 8,174,884	$ 13,255,887
Cost of revenues	4,302,370	4,748,444
Gross profit	3,872,514	8,507,443
Operating expenses
Bad Debt	774,312
General and administrative	3,584,721	3,917,935
Sales and marketing	4,002,565	2,325,709
Engineering, research, and development	3,583,773	3,535,742
Goodwill impairment	85,169
Intangible asset impairment	8,286	8,886
Depreciation and amortization	707,073	674,942
Total operating expenses	12,745,899	10,463,214
Loss from operations	(8,873,385)	(1,955,771)
Other income/(expense)
Interest income	5	1,221
Gain on Extinguishment of Debt	891,103
Interest expense	(267,966)	(286,896)
Loss on disposal of fixed assets	(880)	(8,808)
Loss on settlement of debt		(668,260)
Foreign currency gain (loss)	(8,661)	117
Total other income (expense)	613,601	(962,626)
Loss before income taxes	(8,259,784)	(2,918,397)
Income tax expense
Net Loss	(8,259,784)	(2,918,397)
Other comprehensive Income (loss), net of income tax
Foreign currency translation adjustments	(28,642)	(32,226)
Comprehensive loss	$ (8,288,426)	$ (2,950,623)
Net loss per share:
Basic and Diluted	$ (0.15)	$ (0.06)
Weighted average number of shares:
Basic and Diluted	55,410,695	51,575,454

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)	Common Stock [Member]	Equity Payable [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]	Total
Beginning balance, value at Dec. 31, 2019	$ 51,381	$ 100,862	$ 94,781,738	$ 8,780	$ (96,657,106)	$ (1,714,345)
Beginning balance, shares at Dec. 31, 2019	51,380,969
Issuance of common stock for cash	$ 1,556		1,932,411			$ 1,933,967
Issuance of common stock for cash, Shares	1,556,459					1,113,767
Issuance of common stock for warrants exercised	$ 1,114		2,059,354			$ 2,060,468
Issuance of common stock for debt settlement	$ 1,360		1,639,448			1,640,808
Issuance of common stock for debt settlement, Shares	1,359,500
Issuance of common stock for warrants exercised, Shares	1,113,767
Stock based compensation			773,938			773,938
Foreign currency translation adjustment				(32,226)		(32,226)
Net loss					(2,918,397)	(2,918,397)
Ending balance, value at Dec. 31, 2020	$ 55,411	100,862	101,186,889	(23,446)	(99,575,503)	$ 1,744,213
Ending balance, shares at Dec. 31, 2020	55,410,695
Issuance of common stock for cash, Shares						0
Fair value of options issued with related party debt			262,758			$ 262,758
Stock based compensation			997,274			997,274
Foreign currency translation adjustment				(28,642)		(28,642)
Net loss					(8,259,784)	(8,259,784)
Ending balance, value at Dec. 31, 2021	$ 55,411	$ 100,862	$ 102,446,921	$ (52,088)	$ (107,835,287)	$ (5,284,181)
Ending balance, shares at Dec. 31, 2021	55,410,695

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
OPERATING ACTIVITIES
Net loss	$ (8,259,784)	$ (2,918,397)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense	774,312	25,583
Loss on settlement of debt		668,260
Gain on Extinguishment of Debt	(891,103)
Stock-based compensation	997,274	773,938
Loss on disposal of fixed assets	880	8,808
Intangible Asset Impairment	8,286	8,886
Goodwill impairment	85,169
Depreciation and amortization expense	707,073	696,574
Amortization of debt discount	31,000
Increase (decrease) in cash resulting from changes in:
Accounts receivable	(365,213)	282,734
Contracts receivable, current		(416,956)
Other current assets	40,133	338,233
Operating lease assets/liabilities	(2,575)	(33,590)
Contracts receivable, long-term	707,928	(155,485)
Other assets	2,330	14,040
Accounts payable	1,888,498	(1,321,012)
Accrued interest	168,673	204,232
Accrued and deferred personnel compensation	270,590	(20,402)
Other liabilities - non-current	(415,766)	91,317
Other liabilities - current	(2,876)	257,838
Deferred revenue and customer deposits	(229,427)	166,288
Net cash used in operating activities	(4,484,598)	(1,329,111)
INVESTING ACTIVITIES
Purchases of equipment	(79,219)	(13,325)
Cash paid for patent		(17,505)
Capitalized software development costs	(299,253)	(266,365)
Net cash used in investing activities	(378,472)	(297,195)
FINANCING ACTIVITIES
Payments on notes payable	(561,528)	(473,586)
Payments on related party notes payable	(280,000)	(60,700)
Proceeds from notes payable		920,990
Proceeds from related party notes payable	3,206,250	700,000
Proceeds from issuance of common stock, net of issuance costs		3,574,775
Net cash provided by financing activities	2,364,722	4,661,479
Effect of foreign currency translation on cash flow	(49,048)	(25,952)
Net change in cash	(2,547,396)	3,009,221
Cash at beginning of period	3,282,820	273,599
Cash at end of period	735,424	3,282,820
Cash paid during period for:
Interest	68,389	75,464
Taxes		851
Non-cash investing and financing activities:
Initial ROU asset and lease liability	1,458,527	$ 1,392,208
Debt Discount on Related Party Debt	262,658
Fixed assets contributed by lessor	110,000
Refinancing of debt - related party	$ 43,750

Nature of Operations

Nature of Operations	12 Months Ended
	Dec. 31, 2021
Nature of Operations [Abstract]
Nature of Operations	1. Nature of Operations Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven marketing campaigns.  Mobivity’s Recurrency platform enables multi-unit retailers to leverage the power of their own data to yield maximum customer spend, frequency and loyalty while achieving the highest Return on Marketing Spend (ROMS) possible. Mobivity’s customers use Recurrency to: Transform messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence.Measure, predict, and boost guest frequency and spend by channel.Deploy and manage one-time use offer codes and attribute sales accurately across every channel, promotion and media program.Deliver 1:1 promotions and offers with customized Mobile Messaging, Personalized Receipt Promotions and Integrated Loyalty programs. Mobivity’s Recurrency, delivered as a SaaS platform, is used by leading brands including Subway, Sonic Drive-In, Chick-fil-A, Checkers/Rally’s and Circle K’s across more than 40,000 retail locations globally. We’re living in a data-driven economy. In fact, by 2003 — when the concept of “big data” became common vernacular in marketing - as much data was being created every two days as had been created in all of time prior to 2003. Today, Big Data has grown at such a rate that 90% of the world’s data has been created in the past two years. Unfortunately, despite there being so much data accumulated, only one percent of data is being utilized today by most businesses. The challenge for multi-unit retailers isn’t that they don’t have enough data; in fact, national retailers are collecting millions of detailed transactions daily from thousands of points of sale around the world. The challenge is being able to make sense of this transaction data, which is riddled with data entry errors, collected by multiple POS systems and complicated by a taxonomy compiled by thousands of different franchisee owners. To normalize such an overwhelming amount of data into usable intelligence and then leverage it to optimize media investment and promotion strategy requires numerous teams of data analysts and data scientists that many retailers and restaurant operators simply don’t have. Which is why so many technology and data companies, that can help solve these challenges, have been invested in and acquired by brands including, McDonald’s, Starbucks and Yum Brands. Mobivity’s Recurrency platform fills this need with a self-service SaaS offering, enabling operators to intelligently optimize their promotions, media and marketing spend. Recurrency drives system-wide sales producing on average a 13% increase in guest spend and a 26% improvement in frequency, ultimately delivering an average Return on Marketing Spend of 10X. In other words, for every dollar invested in marketing, retailers using Recurrency to manage, optimize and deliver multi-channel consumer promotions generate an average of ten dollars in incremental revenue from their customers. We generate revenue by charging the resellers, brands and enterprises a per-message transactional fee, or through fixed or variable software licensing fees.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Live Lenz Inc. All significant intercompany balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may differ from these estimates. Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no effect on previously reported net loss. Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill. Cash and Cash Equivalents We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts. Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of December 31, 2021 and 2020, we recorded an allowance for doubtful accounts of $56,340 and $33,848, respectively. From time to time, we may have a limited number of customers with individually large amounts due. Any unanticipated change in one of the customer’s credit worthiness could have a material effect on the results of operations in the period in which such changes or events occurred. As of December 31, 2021, we had three customer whose balance represented 94% of total accounts receivable. As of December 31, 2020, we had two customers whose balance represented 77% of total accounts receivable. Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit's carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit. We conducted our annual impairment tests of goodwill as of December 31, 2021 and 2020. As a result of these tests, we a total impairment charges of $85,169. Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to twenty years. No significant residual value is estimated for intangible assets. We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate. The Company’s evaluation of its long-lived assets completed resulted in $8286 and $0 of intangible impairment expense during the years ended December 31, 2021 and December 31, 2020. Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to impairment expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four month period. The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development asset resulted in impairment charges of $0 for the year ended December 31, 2021 and $8,886 for the year ended December 31, 2020. Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate. Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830-10, Foreign Currency Matters (“ASC 830-10”). Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity. Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the unaudited Condensed Consolidated Statements of Income and Comprehensive Income. Derivative Financial Instruments We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue. During the years ended December 31, 2021 and 2020, two customers accounted for 55% and 77% of our revenues, respectively. Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at comprehensive loss. For the twelve months ended December 31, 2021 and 2020, the comprehensive loss was $8,288,426 and $2,950,623 respectively. Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period. Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials. Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements, sales enablement, content creation, and other direct costs. Advertising expense was $962,049 and $399,266 for years ended December 31, 2021 and 2020, respectively. We also include the cost of attending trade shows under marketing expense. We recorded $50,267 and $81,852 of expense related to those activities for the years ended December 31, 2021 and 2020, respectively. Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained. Computation of Net Loss per Common Share Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based on the assumption that all potential common stock equivalents (convertible notes payable, stock options, and warrants) are converted or exercised. The calculation of diluted net loss per share excludes potential common stock equivalents if the effect is anti-dilutive. Our weighted average common shares outstanding for basic and diluted are the same because the effect of the potential common stock equivalents is anti-dilutive. We had the following dilutive common stock equivalents as of December 31, 2021 and 2020 which were excluded from the calculation because their effect was anti-dilutive. December 31, 2021 2020Outstanding employee options 6,246,466 6,007,552Outstanding restricted stock units 1,685,141 1,436,728Outstanding warrants 3,246,690 2,691,459 11,178,297 10,135,739 Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following are a summary of recent accounting developments. In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06” or the “ASU”). ASU No. 2020-06 requires that the if-converted method of computing diluted Earnings per Share. The company adopted January 1, 2022.

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2021
Going Concern [Abstract]
Going Concern	3. Going Concern We have $735,424 of cash as of December 31, 2021. We had a net loss of $8.3 million for the year then ended, and we used $4.5 million of cash in our operating activities during 2021. In 2020, we had a net loss of $2.9 million and used $1.3 million of cash in our operating expenses. We raised $2,530,552 in cash exercise of warrants in February 2022. There is substantial doubt that our additional cash from our warrant conversion along with our expected cash flow from operations, will be sufficient to fund our 12-month plan of operations, there can be no assurance that we will not require significant additional capital within 12 months. As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $107,835,287 as of December 31, 2021. Further losses are anticipated in the development of the Company’s business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with the proceeds from the sale of securities, and/or revenues from operations. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets [Abstract]
Goodwill and Intangible Assets	4. Goodwill and Intangible Assets GoodwillThe following table presents goodwill and impairment for the years ended December 31, 2021 and 2020: GoodwillDecember 31, 2019$ 496,352Acquired —Impairment —December 31, 2020 496,352Acquired —Impairment (85,169)December 31, 2021$ 411,183 We conducted our annual impairment test of goodwill as of December 31, 2021 and 2020, which resulted in impairment charges of $85,169. Intangible assets The following table presents components of identifiable intangible assets for the years ended December 31, 2021 and 2020: December 31, 2021 December 31, 2020 Gross‎Carrying‎Amount Accumulated‎Amortization Net Carrying‎Amount Weighted‎Average‎Useful‎Life‎(Years) Gross‎Carrying‎Amount Accumulated‎Amortization Net Carrying‎Amount Weighted‎Average‎Useful‎Life‎(Years)Patents and trademarks$ 105,543 $ (47,948) $ 57,595 14 $ 197,528 $ (126,499) $ 71,029 14Customer and merchant‎relationships 2,321,112 (1,775,579) 545,533 10 2,321,112 (1,678,727) 642,385 10Trade name 197,955 (165,562) 32,393 10 197,950 (156,506) 41,444 10Acquired technology 621,030 (508,839) 112,191 10 621,030 (492,539) 128,491 10Non-compete agreement 79,300 (50,088) 29,212 2 79,300 (34,228) 45,072 2 $ 3,324,940 $ (2,548,017) $ 776,924 $ 3,416,920 $ (2,488,499) $ 928,421 During the years ended December 31, 2021 and 2020, we recorded amortization expense related to our intangible assets of $163,760 and $150,701, respectively, which is included in depreciation and amortization in the consolidated statement of operations. During the years ended December 31, 2021 and 2020, we recorded impairment of $8,286 and $0 respectively related to our intangible assets. Expected future intangible asset amortization as of December 31, 2021 is as follows: Year ending December 31,Amount2022$ 142,9452023 140,4352024 103,8392025 96,0912025 96,091Thereafter 197,523Total$ 776,924

Software Development Costs

Software Development Costs	12 Months Ended
	Dec. 31, 2021
Software Development Costs [Abstract]
Software Development Costs	5.  Software Development Costs The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activities. The balance is included in the net intangible assets on the balance sheet. The following table presents details of our software development costs for the years ended December 31, 2021 and 2020: December 31, 2021 December 31, 2020Gross‎Carrying‎Amount Accumulated‎Amortization Net Carrying‎Amount Weighted‎Average‎Useful‎Life‎(Years) Gross‎Carrying‎Amount Accumulated‎Amortization Net Carrying‎Amount Weighted‎Average‎Useful‎Life‎(Years)$ 2,565,525 $ (2,217,729) $ 347,796 2 $ 2,266,272 $ (1,826,364) $ 439,908 2$ 2,565,525 $ (2,217,729) $ 347,796 $ 2,266,272 $ (1,826,364) $ 439,908 Software development costs are being amortized on a straight-line basis over their estimated useful life of two years. During the years ended December 31, 2021 and 2020, we capitalized $299,253 and $266,365 respectively of software development. We recorded amortization expense for software development costs of $391,365 and $518,087, respectively which is included in depreciation and amortization in the consolidated statement of operations. During the years ended December 31, 2021 and 2020, we recorded impairment charges of $0 and $8,886, respectively related to our software development costs. The estimated future amortization expense of software development costs as of December 31, 2021 is as follows: Year ending December 31,Amount2022 255,5012023 92,2882024 82025 —2025 —Thereafter —Total$ 347,797

Operating Lease Assets

Operating Lease Assets	12 Months Ended
	Dec. 31, 2021
Operating Lease Assets [Abstract]
Operating Lease Assets	6.  Operating Lease Assets Adoption of Accounting Standards Codification (“ASC”) Topic 842, “Leases." The Company adopted Topic 842 on January 1, 2019, using the modified retrospective method and the optional transition method to record the adoption impact through a cumulative adjustment to equity. Results for reporting periods beginning after January 1, 2019, are presented under Topic 842, while prior periods are not adjusted and continue to be reported under the accounting standards in effect for those periods. The following are additional details related to leases recorded on our balance sheet as of December 31, 2020: LeasesClassification Balance at ‎December 31,‎2021Assets Current Operating lease assetsOperating lease assets $ —Noncurrent Operating lease assetsNoncurrent operating lease assets 1,187,537Total lease assets $ 1,187,537 Liabilities Current Operating lease liabilitiesOperating lease liabilities $ 229,240Noncurrent Operating lease liabilitiesNoncurrent operating lease liabilities $ 1,188,589Total lease liabilities $ 1,417,829 During the year ended December 31, 2021, we recorded amortization expense of $106,302 and during the year ended December 31, 2020, we recorded a credit to amortization expense of $17,214 related to the accretion of the lease liability, which is included in depreciation and amortization in the consolidated statement of operations. Rent expense was $258,368 and $317,774 for the years ended December 31, 2021 and 2020, respectively. We have entered into a new lease starting in February of 2021 for 8,898 square feet of office space located at 3133 W. Frye Road, Suite 215, Chandler, Arizona. Monthly rental payments, excluding common area maintenance charges, will be $25,953 to $28,733. The first twelve months of the lease includes a 50% abatement period. An operating lease asset and liability will be recorded when the lease commences in accordance with ASC 842.The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term and weighted average discount rate: Year ending December 31,Amount2022$ 318,0552023 324,2202024 330,8942025 337,5672026 344,241Thereafter 28,735 Total future lease payments 1,683,712   Less: imputed interest (265,883)Total$ 1,417,829 Weighted Average Remaining Lease Term (years)    Operating leases 6.00 Weighted Average Discount Rate    Operating leases 6.75%

Notes Payable and Interest Expe

Notes Payable and Interest Expense	12 Months Ended
	Dec. 31, 2021
Notes Payable and Interest Expense [Abstract]
Notes Payable and Interest Expense	7. Notes Payable and Interest ExpenseNotes Payable The following table presents details of our notes payable as of December 31, 2021 and 2020: Facility Maturity Interest Rate Balance at December 31, 2021 Balance at ‎December 31,‎2020BDC Term Loan October 15, 2021 23.5% $ — $ 160,088ACOA Note February 1, 2024 — 76,642 111,430Wintrust Bank November 1, 2021 Prime + 1.5% — 366,666TD Bank December 31, 2022 — 31,496 31,390Chase Bank April 10, 2022 1% — 891,103Related Party Notes various 15% 3,318,242 580,000Total Debt 3,426,380 2,140,677Less current portion (888,583) (641,676)Long-term debt, net of current portion $ 2,537,797 $ 1,499,001 Principal payments on notes payables are due as follows: Year ending December 31,Amount2022$ 1,106,6762023 1,808,5232024 447,2312025 63,9502026 —Thereafter — Total future debt payments 3,426,380 ‎ BDC Term Loan On January 8, 2016, Livelenz, a wholly-owned subsidiary of the Company (“Livelenz”), entered into an amendment of their original loan agreement dated August 26, 2011 with the Business Development Bank of Canada (“BDC”). Under this agreement the loan would have matured, and the commitments would have terminated on September 15, 2019. On July 26, 2019, Livelenz, entered into an amendment of their original loan agreement dated August 26, 2011 with the Business Development Bank of Canada (“BDC”). Under this agreement the loan will mature, and the commitments will terminate on October 15, 2021. In accordance with the amendment, the Company will commence monthly payments beginning on August 15, 2019 of principal in the amount of $8,500 CAD in addition to the monthly payment of accrued interest at 23.5%. These payments increased to $10,000 CAD on November 15, 2019, $12,000 CAD on May 15, 2020, and will increase to $14,000 CAD on March 15, 2021with the final payments of $16,000 CAD on September 15, 2021. During year ended December 31, 2021 the BDC loan was repaid in full with the final payment $80,000 CAD on October 15, 2021 in addition to the monthly interest. During the twelve months ended December 31, 2020 we repaid $88,000 CAD of principal. ACOA Note On November 6, 2017, Livelenz (a wholly-owned subsidiary of the Company), entered into an amendment of the original agreement dated December 2, 2014 with the Atlantic Canada Opportunities Agency (“ACOA”). Under this agreement the note will mature without interest and repayments began on June 1, 2016, while the commitments will terminate on February 1, 2024. The monthly principal payment amount of $3,000 CAD increased to $3,500 CAD beginning on November 1, 2019, and will increase to $4,000 CAD on August 1, 2021, $4,500 CAD on August 1, 2022 and $2,215 CAD during the remaining term of the agreement. During the twelve months ended December 31, 2020, we repaid $10,485 CAD of principal. Nine months of payments were voluntarily deferred by ACOA due to COVID-19. During the twelve months ended December 31, 2021 $45,052 CAD in principle was paid toward the ACOA loan. Wintrust Loan On November 14, 2018, we entered into a Loan and Security Agreement with Wintrust Bank. The Loan and Security Agreement provides for a single-term loan to us in the original principal amount of $1,000,000.  Interest accrues on the unpaid principal amount at the rate of prime plus 1.5%. The loan is a three-year loan and was interest-only payable for the first six months of the loan. Commencing on May 1, 2019, we made monthly payments of principal in the amount of $33,333 in addition to the monthly payment of accrued interest. The loan is secured by all of our assets other than our intellectual property. We used the proceeds of the loan to re-finance a loan in the principal amount of $1,000,000 we assumed as part of the acquisition of the Belly assets. On August 7, 2020, the Company entered into an amendment of their original loan agreement dated November 14, 2018 with Wintrust Bank. Under this agreement, the covenant calculation was amended to calculate covenants under a borrowing base methodology. The Company had defaulted under the March 31, 2020 and June 30, 2020 covenants, which were waived upon execution of the amendment and there were no defaults after the amendment. During the twelve months ended December 31, 2020, we repaid $400,000 of principal. The loan was paid in full on June 30, 2021. Chase Loan On April 10, 2020, we entered into a commitment loan with Chase Bank, N.A. under the CARES act and SBA Paycheck Protection Program, in the principal aggregate amount of $891,103, which is due and payable two years after issuance. This note bears interest on the unpaid balance at the rate of one percent (1%) per annum. The note contains a deferral period of six months, for which no interest or principal payments are due. Forgiveness of the loan may be obtained by meeting certain SBA requirements. The entire loan was forgiven on July 21, 2021, at which time the company recorded a gain on extinguishment of debt in the amount of $891,103. TD Bank Loan On April 22, 2020, we entered into a commitment loan with TD Bank under the Canadian Emergency Business Account (“CEBA”), in the principal aggregate amount of $40,000 CAD, which is due and payable on December 31, 2022. This note bears interest on the unpaid balance at the rate of zero percent (0%) per annum during the initial term. Under this note no interest or principal payments are due until December 31, 2022. Under the conditions of the loan, twenty-five percent (25%) of the loan will be forgiven if seventy-five percent (75%) is repaid prior to the initial term date. Related Party Notes During February 2018, we conducted a private placement of Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $1,080,000 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum and the principal and accrued interest is due and payable no later than December 1, 2018. We may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. During 2019, we repaid $1,000,000 and had $80,000 as a remaining balance of these Notes plus accrued interest. As of December 31, 2021 the balance is $0. During the year ended December 31, 2019 we issued unsecured Notes in the principle aggregate amount of $3,500,000, which become due two years after the date of issuance.  These Notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. On July 2, 2019, $2,500,000 of this Note and the accrued interest of $82,916 was settled into equity and we recorded a loss on conversion of debt of $232,462 for the year ended December 31, 2019. As of December 31, 2019, we had a principal balance of $1,080,000 as a remaining balance of these Notes plus accrued interest. On February 26, 2020, we issued an unsecured Note in the principle aggregate amount of $200,000, which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, subject to a two percent (2%) pre-payment penalty. On November 18, 2020, we issued two additional unsecured Notes in the principle aggregate amount of $500,000, which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, subject to a two percent (2%) pre-payment penalty. On December 31, 2020 $1,200,000 of these Notes and the accrued interest of $192,208 was settled into equity and we recorded a loss on settlement of debt of $668,260 for the year ended December 31, 2020. In summary, as of December 31, 2020, we have a principal balance of $580,000 and accrued interest of $42,492 outstanding. On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with one of the Company’s directors. The Company can borrow up to $3,500,000 under this Credit Agreement. On November 19, 2021, a payment of $200,000 was paid toward the principal balance of the note. As of December 31, 2021, the company has drawn a total of $3,478,125 including cash in the amount of $3,206,250 and $271,875 of principal and accrued interest under the above-described Note that was rolled into the Credit Facility. As of December 31, 2021, we have accrued interest of $149,040. The loan is secured by all our tangible and intangible assets including intellectual property. We will repay the principal amount plus accrued interest in 24 equal monthly installments commencing on June 30, 2022, and ending on June 30, 2024. This loan bears interest on unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, penalty or charge. In consideration of the lender’s agreement to provide the facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $1.67 per share in connection with the issuance of funds under this Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the lender additional warrants entitling the lender to purchase a number of shares of the Company common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume weighted average price over the 30 trading days preceding the advance (VWAP). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP. During the twelve month period ending December 31, 2021, the Company issued warrants to purchase an aggregate of 600,570 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is $262,758 using the Black-Scholes option valuation model as of December 31, 2021. On July 1, 2021 we entered into an Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $271,875 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum and the principal and accrued interest is due and payable no later than July 1, 2023. We may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. The Company issued warrants to purchase an aggregate of 33,017 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. During the twelve month period ending December 31, 2021, the Company issued warrants to purchase an aggregate of 600,570 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is $262,758 using the Black-Scholes option valuation model as of December 31, 2021. Interest Expense The following table summarizes interest expense for the years ended December 31, 2021 and 2020: December 31, 2021 2020Interest expense$ 267,966 $ 286,896Total interest expense$ 267,966 $ 286,896

Common Stock and Equity Payable

Common Stock and Equity Payable	12 Months Ended
	Dec. 31, 2021
Common Stock and Equity Payable [Abstract]
Common Stock and Equity Payable	8. Common Stock and Equity Payable Common Stock 2020 On March 2, 2020, the Company issued 234,500 shares of common stock in exchange for cash in conjunction with a warrant exercise. The shares were exercised at the strike price of $1.00 per share. On September 17, 2020, the Company issued 15,000 shares of common stock in exchange for cash in conjunction with a stock option exercise. The shares were exercised at the strike price of $0.48 per share. In December of 2020, the Company commenced a private placement of its common stock with warrant exercises for one unit of our common stock at an exercise price of $1.25 per share to receive a new warrant to purchase to one share of our common stock at an exercise price of $2.00 per share. As of December 31, 2020, the Company had sold 2,666,459 units of its common stock for gross proceeds of $3,333,074. In addition, the Company issued 1,113,767 units of its common stock associated with the settlement of $1,200,000 of principal, $192,208 of accrued interest, and a loss on settlement of $668,260 (See Note 6). On December 31, 2021, the Company recorded stock-based compensation expense of $260,003 related to restricted stock units for members of our board of directors. As of December 31, 2020 we had an equity payable balance of $100,862. 2021 During the year ended December 31, 2021, the Company did not issue any shares but, recorded stock-based compensation expense of $260,005 related to restricted stock units for members of our board of directors. The company recorded stock-based compensation expense of $187,501 related to restricted stock units for employee compensation.

Stock-based Plans and Stock-bas

Stock-based Plans and Stock-based Compensation	12 Months Ended
	Dec. 31, 2021
Stock-based Plans and Stock-based Compensation [Abstract]
Stock-based Plans and Stock-based Compensation	9. Stock-based Plans and Stock-based Compensation Stock-based Plans We have the 2010 Incentive Stock Option Plan and the 2013 Incentive Stock Option Plan under which we have granted stock options to our directors, officers and employees. As of December 31, 2021, 6,246,466 shares were authorized under the plans and 30,263,320 shares were available for future grant. We believe that such awards better align the interests of our directors, officers and employees with those of our shareholders. Option awards are generally granted with an exercise price that equals the fair market value of our stock at the date of grant. These option awards generally vest based on four years of continuous service and have 10-year contractual terms. The following table summarizes stock option activity under our stock-based plans as of and for the years ended December 31, 2021 and 2020: Shares Weighted‎Average‎Exercise Price Weighted‎Average‎Remaining‎Contractual‎Term (Years) Aggregate‎Intrinsic ValueOutstanding at December 31, 2019 5,781,884 $ 1.15 7.16 $ 527,868Granted 1,545,000 $ 1.19 — $ —Exercised (15,000) $ 0.48 — $ —Forfeit/canceled (814,068) $ 0.94 — $ —Expired (490,264) $ 1.07 — $ —Outstanding at December 31, 2020 6,007,552 $ 1.20 6.77 $ 4,056,639Granted 637,500 $ 1.56 — $ —Exercised — $ 1.61 — $ —Forfeit/canceled (272,029) $ 2.18 — $ —Expired (126,557) $ 1.17 — $ —Outstanding at December 31, 2021 6,246,466 $ 1.20 7.17 $ 2,500,847 Expected to vest at December 31, 2021 6,246,466 $ 1.20 6.14 $ 4,056,639Exercisable at December 31, 2021 4,063,765 $ 1.17 4.84 $ 2,252,766Unrecognized expense at December 31, 2021$ 1,527,647 The aggregate intrinsic value of options was calculated as the difference between the exercise price of the underlying awards and the quoted price of our common stock. At December 31, 2021, options to purchase 1,692,332 shares of common stock were in-the-money. The weighted average grant-date fair value of options granted during the years 2021 and 2020 was $0.99 and $0.79, respectively. 2020 On March 24, 2020, the Company granted one employee a total of 15,000 options to purchase shares of the Company common stock at the closing price as of March 24, 2020 of $0.65 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until March 24, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.56% and an option fair value of $0.43 was $6,472. On April 6, 2020, the Company granted four employees a total of 700,000 options to purchase shares of the Company common stock at the closing price as of April 6, 2020 of $0.70 per share. 500,000 option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until April 6, 2030. 200,000 option shares will vest ratably over forty-eight (48) months and are exercisable until April 6, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 78.21% and an option fair value of $0.47 was $326,752. On November 5, 2020, the Company granted one employee a total of 20,000 options to purchase shares of the Company common stock at the closing price as of November 5, 2020 of $0.96 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until November 5, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.36% and an option fair value of $0.63 was $12,689. On December 7, 2020, the Company granted one employee a total of 600,000 options to purchase shares of the Company common stock at the closing price as of December 7, 2020 of $1.55 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until December 7, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.35% and an option fair value of $1.03 was $615,495. On December 17, 2020, the Company granted six employees a total of 210,000 options to purchase shares of the Company common stock at the closing price as of December 17, 2020 of $1.83 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until December 17, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.41% and an option fair value of $1.21 was $254,373. 2021 On March 26, 2021, the Company granted five employee a total of 67,500 options to purchase shares of the Company common stock at the closing price as of March 26, 2021, of $1.80 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until March 26, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.97% and an option fair value of $1.16 was $78,492. On May 17, 2021, the Company granted one employee a total of 20,000 options to purchase shares of the Company common stock at the closing price as of May 17, 2021, of $1.67 per share. The option shares will vest ratably over forty-eight (48) months and are exercisable until January 21, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 74.79% and an option fair value of $0.93 was $18,628. On August 11, 2021, the Company granted one employee a total of 5,000 options to purchase shares of the Company common stock at the closing price as of August 11, 2021, of $1.53 per share. The option shares will vest ratably over forty-eight (48) months and are exercisable until August 11, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.29% and an option fair value of $1.12 was $5,606. On December 15, 2021, the Company granted nineteen employees a total of 545,000 options to purchase shares of the Company common stock at the closing price as of December 15, 2021, of $1.53 per share. The option shares will vest ratably over forty-eight (48) months and are exercisable until February 18, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 71.53% and an option fair value of $.97 was $528,434. Stock-based Compensation Expense The impact on our results of operations of recording stock-based compensation expense for the years ended December 31, 2021 and 2020 was as follows: Years Ended December 31, 2021 2020General and administrative$ 289,782 $ 267,306Sales and marketing 81,093 75,235Engineering, research, and development 178,893 171,394 $ 549,768 $ 513,935 As of December 31, 2021, there was approximately $1,527,647 of unearned stock-based compensation that will be expensed from 2022 through 2026. If there are any modifications or cancellations of the underlying unvested awards, we may be required to accelerate, increase or cancel all or a portion of the remaining unearned stock-based compensation expense. Future unearned stock-based compensation will increase to the extent we grant additional equity awards. Stock Option Valuation Assumptions We calculated the fair value of each stock option award on the date of grant using the Black-Scholes option pricing model. The ranges of assumptions were used for the years ended December 31, 2021 and 2020:     Years Ended December 31,    2021 2020Risk-free interest rate  0.42% to 0.58% 0.42% to 0.58%Expected life (years)  6.00 6.00Expected dividend yield  — —Expected volatility  59.90% to 80.26% 77.36% to 78.21% The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options. The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of its stock-based awards. The dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts. The expected volatility in 2021 and 2020 is based on the historical publicly traded price of our common stock. Restricted stock units The following table summarizes restricted stock unit activity under our stock-based plans as of and for the years ended December 31, 2021 and 2020:   Shares Weighted Average‎Grant Date Fair Value Weighted Average‎Remaining‎Contractual Term‎(Years) Aggregate‎Intrinsic ValueOutstanding at December 31, 2019 1,152,248 $ 0.86 — $ 1,120,404Awarded 284,480 $ 0.91 — $ 60,003Released — $ — — $ —Canceled/forfeited/expired — $ — — $ —Outstanding at December 31, 2020 1,436,728 $ 0.86 — $ 1,180,407Awarded 654,663 $ 1.77 — $ 260,005Released — $ — — $ —Canceled/forfeited/expired (406,250) $2 — $ (192,339)Outstanding at December 31, 2021 1,685,141 $ 1.18 — $ 1,248,073 Vested at December 31, 2021 1,685,141 $ — — $ 2,595,117Unvested at December 31, 2021 — $ — — $ —Unrecognized expense at December 31, 2021$ — ‎2020 On March 24, 2020, the Company issued to four independent directors a total of 100,000 restricted stock units. These restricted stock units were issued for the $65,000 of board compensation earned for the first quarter of 2020. The units were valued at $65,000 or $0.65 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) March 24, 2023, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On August 7, 2020, the Company granted four independent directors a total of 81,252 restricted stock units. The units were valued at $65,000 or $0.80 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) August 7, 2023, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On November 5, 2020, the Company granted four independent directors a total of 67,708 restricted stock units. The units were valued at $65,000 or $0.96 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) November 5, 2023, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On December 17, 2020, the Company granted four independent directors a total of 35,520 restricted stock units. The units were valued at $65,000 or $1.83 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) December 17, 2023, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. In the twelve months ended December 31, 2020, the company recorded $260,003 respectively, in restricted stock units as board compensation. 2021 On March 26, 2021 an employee was granted 500,000 restricted stock units. These restricted stock units were issued as compensation The units were valued at $900,000 or $1.80 per share, based on the closing stock price on the date of grant. units vested 1/48th monthly for four years. The total units vested in 2021 were 114,583. On March 26, 2021 the Company issued to four independent directors a total of 36,112 restricted stock units. These restricted stock units were issued for the $65,000 of board compensation earned for the first quarter of 2021. The units were valued at $65,000 or $1.80 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) March 26, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On May 12, 2021, the Company granted four independent directors a total of 38,924 restricted stock units. The units were valued at $65,000 or $1.67 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) May 12, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On August 11, 2021, the Company granted four independent directors a total of 37,144 restricted stock units. The units were valued at $65,000 or $1.75 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) August 11, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On December 15, 2021, the Company granted four independent directors a total of 42,484 restricted stock units. The units were valued at $65,000 or $1.53 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) December 15, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. In the twelve months ended December 31, 2021, the company recorded $447,506 in restricted stock units as board compensation. Restricted Stock Unit Compensation Expense The impact on our results of operations of recording stock-based compensation expense for years ended December 31, 2021 and 2020 was as follows: Years Ended December 31, 2021 2020General and administrative$ 260,005 $ 260,003Sales and Marketing 187,501 — $ 447,506 $ 260,003

Warrants to Purchase Common Sto

Warrants to Purchase Common Stock	12 Months Ended
	Dec. 31, 2021
Warrants to Purchase Common Stock [Abstract]
Warrants to Purchase Common Stock	10. Warrants to Purchase Common Stock The following table summarizes investor warrant activity as of and for the years ended December 31, 2021 and 2020: Shares Weighted‎Average‎Exercise‎Price Weighted‎Average‎Remaining‎Contractual‎Term (Years)Outstanding at December 31, 2019 3,358,459 $ 1.23 1.27Granted 2,666,459 $ — —Exercised (2,900,959) $ — —Canceled/forfeited/expired (432,500) $ — —Outstanding at December 31, 2020 2,691,459 $ 1.99 2.94Granted 580,231 $ — —Exercised — $ — —Canceled/forfeited/expired (25,000) $ — —Outstanding at December 31, 2021 3,246,690 $ 2.26 3.59 We did not record any stock-based compensation expense for the years ended December 31, 2021 and 2020, respectively in connection with the exercise of investor-based warrants. Warrants Exercised in 2020 During year ending December 31, 2021 no warrants were exercized.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Taxes [Abstract]
Income Taxes	11. Income Taxes On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) was enacted and signed into law in response to the market volatility and instability resulting from the COVID-19 pandemic. It includes a significant number of tax provisions and lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 (the 2017 Act). The changes are mainly related to: (1) the business interest expense disallowance rules for 2019 and 2020; (2) net operating loss rules; (3) charitable contribution limitations; (4) employee retention credit; and (5) the realization of corporate alternative minimum tax credits. The Company does not anticipate the application of the CARES Act provisions to materially impact the overall Consolidated Financial Statements. For the years ended December 31, 2021 and 2020 the provisions for income taxes were as follows: 2021 2020Federal – current$ — $ —State – current — —Foreign – current — —Total$ — $ — Under ASC 740, deferred income tax assets and liabilities reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our net deferred tax assets and liabilities as of December 31, 2021 and 2020 are as follows: 2021 2020Deferred tax assets (liabilities): Net operating loss carryforwards$ 16,915,000 $ 14,881,000Stock based compensation 4,372,000 4,094,000Accrued compensation 31,000 19,000Depreciation and amortization 3,783,000 3,867,000Other 2,000 —Total deferred tax assets 25,103,000 22,861,000Valuation allowance for net deferred tax assets (25,103,000) (22,861,000)Total$ — $ — The Company has provided a valuation allowance against deferred tax assets recorded as of December 31, 2021 and 2020 due to uncertainties regarding the realization of such assets. The net change in the total valuation allowance for the year ended December 31, 2021 was an increase of approximately $2,479,000. The net change in the total valuation allowance for the year ended December 31, 2020 was an increase of approximately $568,000. In assessing the valuation of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during periods in which those temporary differences become deductible. The Company considers projected future taxable income and planning strategies in making this assessment. Based on the level of historical operating results and projections for the taxable income for the future, the Company has determined that it is more likely than not that the deferred tax assets will not be realized. Accordingly, the Company has recorded a valuation allowance to reduce deferred tax assets to zero. There can be no assurance that the Company will ever be able to realize the benefit of some or all of the federal and state loss carryforwards, either due to ongoing operating losses orf due to ownership changes, which limit the usefulness of the loss carryforwards. As of December 31, 2021, the Company has available net operating loss carryforwards of approximately $64,000,000 for federal income tax purposes, which will start to expire in 2026. The net operating loss carryforwards for state purposes are approximately $61,000,000 and will start to expire in 2028. The difference between the provision for income taxes and income taxes computed using the U.S. federal income tax rate for the years ended December 31, 2021 and 2020 was as follows: 2021 2020Computed expected tax expense$ (1,735,000) $ (613,000)State taxes, net of federal benefit (799,000) (141,000)Expiration of NOL carryforwards 87,000 44,000Other (32,000) 142,000Change in valuation allowance 2,479,000 568,000Total$ — $ — The Company has determined that during 2010 it experienced a “change of ownership” as defined by Section 382 of the Internal Revenue Code. As such, utilization of net operating loss carryforwards and credits generated before the 2010 change in ownership will be limited to approximately $207,000 per year until such carryforwards are fully utilized. The pre change net operating loss carryforward was approximately $6,000,000. Since 2010 the Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382, at any time since 2010, utilization of the net operating loss carryforwards tax credit carryforwards would be subject to further annual limitation under Section 382. Any limitation may result in expiration of a portion of the net operating loss carryforwards before utilization. The Company files income tax returns in the U.S. federal jurisdiction, Arizona, and California. Because the Company is carrying forward federal and state net operating losses from 2006, the Company is subject to U.S. federal and state income tax examinations by tax authorities for all years since 2006. The Company does not have a liability for any uncertain tax positions. As of December 31, 2021, no accrued interest or penalties are recorded in the financial statements.

Fair Value Measurements of Fina

Fair Value Measurements of Financial Instruments	12 Months Ended
	Dec. 31, 2021
Fair Value Measurements of Financial Instruments [Abstract]
Fair Value Measurements of Financial Instruments	12. Fair Value Measurements of Financial Instruments The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2021: DescriptionLevel 1 Level 2 Level 3 Gains (Losses)Goodwill (non-recurring)$ — $ — $ 411,183 $ —Intangibles, net (non-recurring)$ — $ — $ 1,124,720 $ — The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2020: DescriptionLevel 1 Level 2 Level 3 Gains (Losses)Goodwill (non-recurring)$ — $ — $ 496,352 $ —Intangibles, net (non-recurring)$ — $ — $ 1,368,329 $ — The Company recorded goodwill, intangible assets and an earn-out payable as a result its business combinations, and these assets were valued with the assistance of a valuation consultant and consisted of Level 3 valuation techniques. The Company’s financial instruments consist of cash, accounts receivable, accounts payable, and accrued liabilities. The estimated fair value of cash, accounts receivable, accounts payable and accrued liabilities approximate their carrying amounts due to the short-term nature of these instruments. None of these instruments are held for trading purposes.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies [Abstract]
Commitments and Contingencies	13. Commitments and Contingencies Litigation As of the date of this report, the company has one pending legal proceeding related to TCPA (Telephone Consumer Protection Act) Violation. We are currently in the process of settling with the claimant. Operating Lease As described in Note 6, the Company had a lease through January 2021 for 10,395 square feet of office space located at 55 N. Arizona Ave., Suite 310, Chandler, Arizona. Monthly rental payments, excluding common area maintenance charges, are $20,140. As of December 31, 2021, we have an operating lease asset balance for this lease of $0 and an operating lease liability balance for this lease of $0 recorded in accordance with ASC 842. We have entered into a new lease starting in February of 2021 for 8,898 square feet of office space located at 3133 W. Frye Road, Suite 215, Chandler, Arizona. Monthly rental payments, excluding common area maintenance charges, will be $25,953 to $28,733. The first twelve months of the lease included a 50% abatement period. As of December 31, 2021, we have an operating lease asset balance for this lease of $1,177,094 and an operating lease liability balance for this lease of $1,404,533 recorded in accordance with ASC 842. The Company also has a lease through April 2022 for 3,248 square feet of office space located in Halifax, Nova Scotia, at a monthly rental expense of $3,371 per month, excluding common area maintenance charges. As of December 31, 2021, we have an operating lease asset balance for this lease of $10,443 and an operating lease liability balance for this lease of $13,296 recorded in accordance with ASC 842.

Employee Benefit Plan

Employee Benefit Plan	12 Months Ended
	Dec. 31, 2021
Employee Benefit Plan [Abstract]
Employee Benefit Plan	14. Employee Benefit Plan The Company has an employee savings plan (the “Plan”) pursuant to Section 401(k) of the Internal Revenue Code (the “Code”), covering all of its employees. Participants in the Plan may contribute a percentage of compensation, but not in excess of the maximum allowed under the Code. The Company may make contributions at the discretion of its Board of Directors. During the years ended December 31, 2021 and 2020, the Company made no contributions to the Plan.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	15. Related Party Transactions Unsecured Promissory Note Investments in 2019 During the year ended December 31, 2018, we commenced an offer to certain investors, officers and directors of the Company Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”). In 2019, we issued to one of our directors, unsecured Notes in the principal aggregate amount of $3,500,000, which are due and payable two years after issuance. These notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. We conducted the private placement of our securities in July 2019. The Note holder participated in the private placement by settling principal of $2,500,000 and accrued interest under the notes totaling $82,916, for 2,582,916 units of our securities. The remaining 2019 Notes for $1,000,000 aggregated principal were settled with the December of 2020 private placement. As of December 31, 2020, we have $80,000 as a remaining balance of these Notes and accrued interest of $33,533. Unsecured Promissory Note Investments in 2020 On February 26, 2020, we issued an unsecured Note in the principle aggregate amount of $200,000, which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, subject to a two percent (2%) pre-payment penalty. On November 18, 2020, we issued two additional unsecured Notes in the principle aggregate amount of $500,000, which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, subject to a two percent (2%) pre-payment penalty. On December 31, 2020 $1,200,000 of these Notes and the accrued interest of $192,208 was settled into equity and we recorded a loss on settlement of debt of $668,260 for the year ended December 31, 2020. In summary, as of December 31, 2020, we have a principal balance of $580,000 and accrued interest of $42,492 outstanding. On January 25, 2021, we repaid $65,000 for an unsecured Note. On January 27, 2021, we repaid the remaining $15,000 of the unsecured Note and accrued interest of $34,379. Unsecured Promissory Note Investments in 2021 On July 1, 2021 we entered into an Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $271,875 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum and the principal and accrued interest is due and payable no later than July 1, 2023. We may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. The Company issued warrants to purchase an aggregate of 33,017 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. Secured Promissory Note Investment in 2021 On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with one of the Company’s directors. The Company can borrow up to $3,500,000 under this Credit Agreement. On November 19, 2021, a payment of $200,000 was paid toward the principal balance of the note. On November 19, 2021, a payment of $200,000 was paid toward the principal balance of the note. As of December 31, 2021, the company has drawn a total of $3,478,125 including cash in the amount of $3,206,250 and $271,875 of principal and accrued interest under the above-described Note that was rolled into the Credit Facility. As of December 31, 2021, we have accrued interest of $149,040. The loan is secured by all our tangible and intangible assets including intellectual property. We will repay the principal amount plus accrued interest in 24 equal monthly installments commencing on June 30, 2022 and ending on June 30, 2024. This loan bears interest on unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, penalty or charge. In consideration of the lender’s agreement to provide the facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $1.67 per share in connection with the issuance of funds under this Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the lender additional warrants entitling the lender to purchase a number of shares of the Company common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume weighted average price over the 30 trading days preceding the advance (VWAP). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP. During the twelve month period ending December 31, 2021, the Company issued warrants to purchase an aggregate of 600,570 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is $262,758 using the Black-Scholes option valuation model as of December 31, 2021.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	16. Subsequent Events 2022 Warrants Exercise On February 7, 2022 seventeen warrant holders exercised their common stock purchase warrant for 3,163,190 shares at the exercise price of $.80 per share, resulting in additional capital of $2,530,552. As an inducement for the holder’s exercise of the warrants, we issued the holders 2,530,552 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in February 2025.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policy)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Live Lenz Inc. All significant intercompany balances and transactions have been eliminated.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may differ from these estimates.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no effect on previously reported net loss.
Acquisitions	Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill.
Cash and Cash Equivalents	Cash and Cash Equivalents We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts.
Accounts Receivable, Allowance for Doubtful Accounts and Concentrations	Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of December 31, 2021 and 2020, we recorded an allowance for doubtful accounts of $56,340 and $33,848, respectively. From time to time, we may have a limited number of customers with individually large amounts due. Any unanticipated change in one of the customer’s credit worthiness could have a material effect on the results of operations in the period in which such changes or events occurred. As of December 31, 2021, we had three customer whose balance represented 94% of total accounts receivable. As of December 31, 2020, we had two customers whose balance represented 77% of total accounts receivable.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit's carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit. We conducted our annual impairment tests of goodwill as of December 31, 2021 and 2020. As a result of these tests, we a total impairment charges of $85,169. Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to twenty years. No significant residual value is estimated for intangible assets. We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate. The Company’s evaluation of its long-lived assets completed resulted in $8286 and $0 of intangible impairment expense during the years ended December 31, 2021 and December 31, 2020.
Software Development Costs	Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to impairment expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four month period. The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development asset resulted in impairment charges of $0 for the year ended December 31, 2021 and $8,886 for the year ended December 31, 2020.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.
Foreign Currency Translation	Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830-10, Foreign Currency Matters (“ASC 830-10”). Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity. Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the unaudited Condensed Consolidated Statements of Income and Comprehensive Income.
Derivative Financial Instruments	Derivative Financial Instruments We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.
Revenue Recognition and Concentrations	Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue. During the years ended December 31, 2021 and 2020, two customers accounted for 55% and 77% of our revenues, respectively.
Comprehensive Income (Loss)	Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at comprehensive loss. For the twelve months ended December 31, 2021 and 2020, the comprehensive loss was $8,288,426 and $2,950,623 respectively.
Stock-based Compensation	Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period.
Research and Development Expenditures	Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials.
Advertising Expense	Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements, sales enablement, content creation, and other direct costs. Advertising expense was $962,049 and $399,266 for years ended December 31, 2021 and 2020, respectively. We also include the cost of attending trade shows under marketing expense. We recorded $50,267 and $81,852 of expense related to those activities for the years ended December 31, 2021 and 2020, respectively.
Income Taxes	Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained.
Computation of Net Loss per Common Share	Computation of Net Loss per Common Share Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based on the assumption that all potential common stock equivalents (convertible notes payable, stock options, and warrants) are converted or exercised. The calculation of diluted net loss per share excludes potential common stock equivalents if the effect is anti-dilutive. Our weighted average common shares outstanding for basic and diluted are the same because the effect of the potential common stock equivalents is anti-dilutive. We had the following dilutive common stock equivalents as of December 31, 2021 and 2020 which were excluded from the calculation because their effect was anti-dilutive. December 31, 2021 2020Outstanding employee options 6,246,466 6,007,552Outstanding restricted stock units 1,685,141 1,436,728Outstanding warrants 3,246,690 2,691,459 11,178,297 10,135,739
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following are a summary of recent accounting developments. In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06” or the “ASU”). ASU No. 2020-06 requires that the if-converted method of computing diluted Earnings per Share. The company adopted January 1, 2022.

The Company and Summary of Sign

The Company and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies [Abstract]
Dilutive common stock equivalents	We had the following dilutive common stock equivalents as of December 31, 2021 and 2020 which were excluded from the calculation because their effect was anti-dilutive. December 31, 2021 2020Outstanding employee options 6,246,466 6,007,552Outstanding restricted stock units 1,685,141 1,436,728Outstanding warrants 3,246,690 2,691,459 11,178,297 10,135,739

Goodwill and Purchased Intangib

Goodwill and Purchased Intangibles (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets [Abstract]
Goodwill	The following table presents goodwill and impairment for the years ended December 31, 2021 and 2020: GoodwillDecember 31, 2019$ 496,352Acquired —Impairment —December 31, 2020 496,352Acquired —Impairment (85,169)December 31, 2021$ 411,183
Intangible Assets	The following table presents components of identifiable intangible assets for the years ended December 31, 2021 and 2020: December 31, 2021 December 31, 2020 Gross‎Carrying‎Amount Accumulated‎Amortization Net Carrying‎Amount Weighted‎Average‎Useful‎Life‎(Years) Gross‎Carrying‎Amount Accumulated‎Amortization Net Carrying‎Amount Weighted‎Average‎Useful‎Life‎(Years)Patents and trademarks$ 105,543 $ (47,948) $ 57,595 14 $ 197,528 $ (126,499) $ 71,029 14Customer and merchant‎relationships 2,321,112 (1,775,579) 545,533 10 2,321,112 (1,678,727) 642,385 10Trade name 197,955 (165,562) 32,393 10 197,950 (156,506) 41,444 10Acquired technology 621,030 (508,839) 112,191 10 621,030 (492,539) 128,491 10Non-compete agreement 79,300 (50,088) 29,212 2 79,300 (34,228) 45,072 2 $ 3,324,940 $ (2,548,017) $ 776,924 $ 3,416,920 $ (2,488,499) $ 928,421
Future Amortization Intangible Assets	Expected future intangible asset amortization as of December 31, 2021 is as follows: Year ending December 31,Amount2022$ 142,9452023 140,4352024 103,8392025 96,0912025 96,091Thereafter 197,523Total$ 776,924

Software Development Costs (Tab

Software Development Costs (Tables)	12 Months Ended
	Dec. 31, 2021
Software Development Costs [Abstract]
Software Development Costs	The following table presents details of our software development costs for the years ended December 31, 2021 and 2020: December 31, 2021 December 31, 2020Gross‎Carrying‎Amount Accumulated‎Amortization Net Carrying‎Amount Weighted‎Average‎Useful‎Life‎(Years) Gross‎Carrying‎Amount Accumulated‎Amortization Net Carrying‎Amount Weighted‎Average‎Useful‎Life‎(Years)$ 2,565,525 $ (2,217,729) $ 347,796 2 $ 2,266,272 $ (1,826,364) $ 439,908 2$ 2,565,525 $ (2,217,729) $ 347,796 $ 2,266,272 $ (1,826,364) $ 439,908
Future Amortization of Software	The estimated future amortization expense of software development costs as of December 31, 2021 is as follows: Year ending December 31,Amount2022 255,5012023 92,2882024 82025 —2025 —Thereafter —Total$ 347,797

Operating Lease Assets (Tables)

Operating Lease Assets (Tables)	12 Months Ended
	Dec. 31, 2021
Operating Lease Assets [Abstract]
Additional Details Related to Leases on Balance Sheet	The following are additional details related to leases recorded on our balance sheet as of December 31, 2020: LeasesClassification Balance at ‎December 31,‎2021Assets Current Operating lease assetsOperating lease assets $ —Noncurrent Operating lease assetsNoncurrent operating lease assets 1,187,537Total lease assets $ 1,187,537 Liabilities Current Operating lease liabilitiesOperating lease liabilities $ 229,240Noncurrent Operating lease liabilitiesNoncurrent operating lease liabilities $ 1,188,589Total lease liabilities $ 1,417,829
Schedule of Minimum Lease Payments Including Weighted-Average Remaining Lease Term and Discount Rates	The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term and weighted average discount rate: Year ending December 31,Amount2022$ 318,0552023 324,2202024 330,8942025 337,5672026 344,241Thereafter 28,735 Total future lease payments 1,683,712   Less: imputed interest (265,883)Total$ 1,417,829 Weighted Average Remaining Lease Term (years)    Operating leases 6.00 Weighted Average Discount Rate    Operating leases 6.75%

Notes Payable and Interest Ex_2

Notes Payable and Interest Expense (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Payable and Interest Expense [Abstract]
Schedule of Notes Payable	The following table presents details of our notes payable as of December 31, 2021 and 2020: Facility Maturity Interest Rate Balance at December 31, 2021 Balance at ‎December 31,‎2020BDC Term Loan October 15, 2021 23.5% $ — $ 160,088ACOA Note February 1, 2024 — 76,642 111,430Wintrust Bank November 1, 2021 Prime + 1.5% — 366,666TD Bank December 31, 2022 — 31,496 31,390Chase Bank April 10, 2022 1% — 891,103Related Party Notes various 15% 3,318,242 580,000Total Debt 3,426,380 2,140,677Less current portion (888,583) (641,676)Long-term debt, net of current portion $ 2,537,797 $ 1,499,001
Schedule of Principal Payments on Notes Payable	Principal payments on notes payables are due as follows: Year ending December 31,Amount2022$ 1,106,6762023 1,808,5232024 447,2312025 63,9502026 —Thereafter — Total future debt payments 3,426,380
Summary of Interest Expense	The following table summarizes interest expense for the years ended December 31, 2021 and 2020: December 31, 2021 2020Interest expense$ 267,966 $ 286,896Total interest expense$ 267,966 $ 286,896

Stock-based Plans and Stock-b_2

Stock-based Plans and Stock-based Compensation (Tables)	12 Months Ended
	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Option Activity	The following table summarizes stock option activity under our stock-based plans as of and for the years ended December 31, 2021 and 2020: Shares Weighted‎Average‎Exercise Price Weighted‎Average‎Remaining‎Contractual‎Term (Years) Aggregate‎Intrinsic ValueOutstanding at December 31, 2019 5,781,884 $ 1.15 7.16 $ 527,868Granted 1,545,000 $ 1.19 — $ —Exercised (15,000) $ 0.48 — $ —Forfeit/canceled (814,068) $ 0.94 — $ —Expired (490,264) $ 1.07 — $ —Outstanding at December 31, 2020 6,007,552 $ 1.20 6.77 $ 4,056,639Granted 637,500 $ 1.56 — $ —Exercised — $ 1.61 — $ —Forfeit/canceled (272,029) $ 2.18 — $ —Expired (126,557) $ 1.17 — $ —Outstanding at December 31, 2021 6,246,466 $ 1.20 7.17 $ 2,500,847 Expected to vest at December 31, 2021 6,246,466 $ 1.20 6.14 $ 4,056,639Exercisable at December 31, 2021 4,063,765 $ 1.17 4.84 $ 2,252,766Unrecognized expense at December 31, 2021$ 1,527,647
Stock-Based Compensation Expense	The impact on our results of operations of recording stock-based compensation expense for the years ended December 31, 2021 and 2020 was as follows: Years Ended December 31, 2021 2020General and administrative$ 289,782 $ 267,306Sales and marketing 81,093 75,235Engineering, research, and development 178,893 171,394 $ 549,768 $ 513,935
Valuation Assumptions	We calculated the fair value of each stock option award on the date of grant using the Black-Scholes option pricing model. The ranges of assumptions were used for the years ended December 31, 2021 and 2020:     Years Ended December 31,    2021 2020Risk-free interest rate  0.42% to 0.58% 0.42% to 0.58%Expected life (years)  6.00 6.00Expected dividend yield  — —Expected volatility  59.90% to 80.26% 77.36% to 78.21%
Restricted Stock Units RSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation Expense	The impact on our results of operations of recording stock-based compensation expense for years ended December 31, 2021 and 2020 was as follows: Years Ended December 31, 2021 2020General and administrative$ 260,005 $ 260,003Sales and Marketing 187,501 — $ 447,506 $ 260,003
Restricted Stock Unit Activity	The following table summarizes restricted stock unit activity under our stock-based plans as of and for the years ended December 31, 2021 and 2020:   Shares Weighted Average‎Grant Date Fair Value Weighted Average‎Remaining‎Contractual Term‎(Years) Aggregate‎Intrinsic ValueOutstanding at December 31, 2019 1,152,248 $ 0.86 — $ 1,120,404Awarded 284,480 $ 0.91 — $ 60,003Released — $ — — $ —Canceled/forfeited/expired — $ — — $ —Outstanding at December 31, 2020 1,436,728 $ 0.86 — $ 1,180,407Awarded 654,663 $ 1.77 — $ 260,005Released — $ — — $ —Canceled/forfeited/expired (406,250) $2 — $ (192,339)Outstanding at December 31, 2021 1,685,141 $ 1.18 — $ 1,248,073 Vested at December 31, 2021 1,685,141 $ — — $ 2,595,117Unvested at December 31, 2021 — $ — — $ —Unrecognized expense at December 31, 2021$ —

Warrants to Purchase Common S_2

Warrants to Purchase Common Stock (Tables)	12 Months Ended
	Dec. 31, 2021
Warrants to Purchase Common Stock [Abstract]
Summary of Investor Warrant Activity	The following table summarizes investor warrant activity as of and for the years ended December 31, 2021 and 2020: Shares Weighted‎Average‎Exercise‎Price Weighted‎Average‎Remaining‎Contractual‎Term (Years)Outstanding at December 31, 2019 3,358,459 $ 1.23 1.27Granted 2,666,459 $ — —Exercised (2,900,959) $ — —Canceled/forfeited/expired (432,500) $ — —Outstanding at December 31, 2020 2,691,459 $ 1.99 2.94Granted 580,231 $ — —Exercised — $ — —Canceled/forfeited/expired (25,000) $ — —Outstanding at December 31, 2021 3,246,690 $ 2.26 3.59

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Taxes [Abstract]
Provisions for Income taxes	For the years ended December 31, 2021 and 2020 the provisions for income taxes were as follows: 2021 2020Federal – current$ — $ —State – current — —Foreign – current — —Total$ — $ —
Net Deferred Tax Assets and Liabilities	Significant components of our net deferred tax assets and liabilities as of December 31, 2021 and 2020 are as follows: 2021 2020Deferred tax assets (liabilities): Net operating loss carryforwards$ 16,915,000 $ 14,881,000Stock based compensation 4,372,000 4,094,000Accrued compensation 31,000 19,000Depreciation and amortization 3,783,000 3,867,000Other 2,000 —Total deferred tax assets 25,103,000 22,861,000Valuation allowance for net deferred tax assets (25,103,000) (22,861,000)Total$ — $ —
Difference Between Provision for Income Taxes and Income Taxes Computed Using Federal Income Tax Rate	The difference between the provision for income taxes and income taxes computed using the U.S. federal income tax rate for the years ended December 31, 2021 and 2020 was as follows: 2021 2020Computed expected tax expense$ (1,735,000) $ (613,000)State taxes, net of federal benefit (799,000) (141,000)Expiration of NOL carryforwards 87,000 44,000Other (32,000) 142,000Change in valuation allowance 2,479,000 568,000Total$ — $ —

Fair Value Measurements of Fi_2

Fair Value Measurements of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Measurements of Financial Instruments [Abstract]
Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2021: DescriptionLevel 1 Level 2 Level 3 Gains (Losses)Goodwill (non-recurring)$ — $ — $ 411,183 $ —Intangibles, net (non-recurring)$ — $ — $ 1,124,720 $ — The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2020: DescriptionLevel 1 Level 2 Level 3 Gains (Losses)Goodwill (non-recurring)$ — $ — $ 496,352 $ —Intangibles, net (non-recurring)$ — $ — $ 1,368,329 $ —

Nature of Operations (Details)

Nature of Operations (Details)	12 Months Ended
	Dec. 31, 2021USD ($)item	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Average percent increase in guess spending using company platform	13.00%
Percent of improvement in frequency using company platform	26.00%
Cash including restricted cash	$ 735,424	$ 3,282,820	$ 273,599
Net loss	(8,259,784)	(2,918,397)
Net cash used in operating activities	$ (4,484,598)	$ (1,329,111)
Minimum [Member]
Number of retail locations where SaaS platform is used | item	40,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Narrative) (Details)	12 Months Ended
	Dec. 31, 2021USD ($)customer	Dec. 31, 2020USD ($)customer
Product Information [Line Items]
Accounts receivable, allowance for doubtful accounts	$ 56,340	$ 33,848
Impairment charges on evaluation of goodwill	85,169
Impairment charges on long-lived assets	8,286	0
Advertising expense	962,049	399,266
Marketing expense	50,267	81,852
Comprehensive loss	$ (8,288,426)	$ (2,950,623)
Software Development Costs [Member]
Product Information [Line Items]
Estimated useful lives	2 years	2 years
Intangible asset impairment	$ 0	$ 8,886
Accounts Receivable [Member]
Product Information [Line Items]
Number of significant customers | customer	3	2
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Product Information [Line Items]
Customer concentration risk	94.00%	77.00%
Sales Revenue Net [Member]
Product Information [Line Items]
Number of significant customers | customer	2	2
Sales Revenue Net [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Product Information [Line Items]
Customer concentration risk	55.00%	77.00%
Minimum [Member]
Product Information [Line Items]
Estimated useful lives	1 year
Maximum [Member]
Product Information [Line Items]
Estimated useful lives	20 years

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Dilutive Common Stock Equivalents) (Details) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculation	11,178,297	10,135,739
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculation	6,246,466	6,007,552
Restricted Stock Units RSU [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculation	1,685,141	1,436,728
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculation	3,246,690	2,691,459

Going Concern (Narrative) (Deta

Going Concern (Narrative) (Details) - USD ($)	1 Months Ended	12 Months Ended
	Feb. 28, 2022	Dec. 31, 2021	Dec. 31, 2020
Going Concern Disclosure [Line Items]
Cash		$ 735,424	$ 3,282,820
Net loss		(8,259,784)	(2,918,397)
Net cash used in operating activities		(4,484,598)	(1,329,111)
Accumulated deficit		$ (107,835,287)	$ (99,575,503)
Subsequent Event [Member]
Going Concern Disclosure [Line Items]
Proceeds from warrant exercises	$ 2,530,552

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 163,760	$ 150,701
Goodwill impairment	85,169
Intangible asset impairment	8,286	8,886
Patents and Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible asset impairment	$ 8,286	$ 0

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Goodwill) (Details)	12 Months Ended
	Dec. 31, 2021USD ($)
Goodwill and Intangible Assets [Abstract]
Goodwill, Beginning Balance	$ 496,352
Impairment	(85,169)
Goodwill, Ending Balance	$ 411,183

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Intangible Assets) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 3,324,940	$ 3,416,920
Accumulated Amortization	(2,548,017)	(2,488,499)
Total	776,924	928,421
Patents and Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	105,543	197,528
Accumulated Amortization	(47,948)	(126,499)
Total	$ 57,595	$ 71,029
Weighted Average Useful Life (Years)	14 years	14 years
Customer and Merchant Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 2,321,112	$ 2,321,112
Accumulated Amortization	(1,775,579)	(1,678,727)
Total	$ 545,533	$ 642,385
Weighted Average Useful Life (Years)	10 years	10 years
Trade Name [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 197,955	$ 197,950
Accumulated Amortization	(165,562)	(156,506)
Total	$ 32,393	$ 41,444
Weighted Average Useful Life (Years)	10 years	10 years
Acquired technology [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 621,030	$ 621,030
Accumulated Amortization	(508,839)	(492,539)
Total	$ 112,191	$ 128,491
Weighted Average Useful Life (Years)	10 years	10 years
Non-compete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 79,300	$ 79,300
Accumulated Amortization	(50,088)	(34,228)
Total	$ 29,212	$ 45,072
Weighted Average Useful Life (Years)	2 years	2 years

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Future Amortization Intangible Assets) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Software Development Costs [Abstract]
2022	$ 142,945
2023	140,435
2024	103,839
2025	96,091
2026	96,091
Thereafter	197,523
Total	$ 776,924	$ 928,421

Software Development Costs (Nar

Software Development Costs (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Capitalized amount of software development	$ 299,253	$ 266,365
Amortization expense	163,760	150,701
Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible asset impairment	0	8,886
Amortization expense	$ 391,365	$ 518,087
Estimated useful lives	2 years	2 years

Software Development Costs (Sof

Software Development Costs (Software Development Costs) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 2,565,525	$ 2,266,272
Accumulated Amortization	(2,217,729)	(1,826,364)
Net Carrying Amount	347,796	439,908
Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,565,525	2,266,272
Accumulated Amortization	(2,217,729)	(1,826,364)
Net Carrying Amount	$ 347,796	$ 439,908

Software Development Costs (Fut

Software Development Costs (Future Amortization of Software) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
2022	$ 142,945
2023	140,435
2024	103,839
2025	96,091
2026	96,091
Thereafter	197,523
Total	776,924	$ 928,421
Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
2022	255,501
2023	92,288
2024	8
2025
2026
Thereafter
Total	$ 347,797

Operating Lease Assets (Narrati

Operating Lease Assets (Narrative) (Details)	1 Months Ended	12 Months Ended
	Feb. 28, 2021USD ($)ft²	Jan. 31, 2022	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)
Lessee, Lease, Description [Line Items]
Amortization expense			$ 106,302
Credit to amortization expense related to accretion of lease liability				$ 17,214
Rent expense			258,368	$ 317,774
Operating lease liability			1,417,829
Fixed assets contributed by lessor			110,000
Lease Starting February 2021 [Member] | Arizona [Member]
Lessee, Lease, Description [Line Items]
Area of office | ft²	8,898
Operating lease liability			$ 1,404,533
Lease Starting February 2021 [Member] | Forecast [Member] | Arizona [Member]
Lessee, Lease, Description [Line Items]
Lease abatement percentage		50.00%
Minimum [Member] | Lease Starting February 2021 [Member] | Arizona [Member]
Lessee, Lease, Description [Line Items]
Rent expense	$ 25,953
Monthly rental expense	25,953
Maximum [Member] | Lease Starting February 2021 [Member] | Arizona [Member]
Lessee, Lease, Description [Line Items]
Rent expense	28,733
Monthly rental expense	$ 28,733

Operating Lease Assets (Additio

Operating Lease Assets (Additional Details Related to Leases on Balance Sheet) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Operating Lease Assets [Abstract]
Noncurrent operating lease assets	$ 1,187,537	$ 57,482
Total lease assets	1,187,537
Operating lease liabilities	229,240	58,173
Noncurrent operating lease liabilities	1,188,589	$ 13,296
Total lease liabilities	$ 1,417,829

Operating Lease Assets (Schedul

Operating Lease Assets (Schedule of Minimum Lease Payments Including Weighted-Average Remaining Lease Term and Discount Rates) (Details)	Dec. 31, 2021USD ($)
Operating Lease
2022	$ 318,055
2023	324,220
2024	330,894
2025	337,567
2026	344,241
Thereafter	28,735
Total future lease payments	1,683,712
Less: imputed interest	(265,883)
Total	$ 1,417,829
Weighted Average Remaining Lease Term (years) Operating leases	6 years
Weighted Average Discount Rate Operating leases	6.75%

Notes Payable and Interest Ex_3

Notes Payable and Interest Expense (Narrative) (Details)

Feb. 01, 2024USD ($)

Oct. 15, 2021CAD ($)

Sep. 15, 2021CAD ($)

Jul. 01, 2021USD ($)shares

Dec. 31, 2020USD ($)

Nov. 18, 2020USD ($)item

Feb. 26, 2020USD ($)

Jul. 02, 2019USD ($)

Nov. 14, 2018USD ($)

Nov. 30, 2021USD ($)

Dec. 31, 2019USD ($)

Feb. 28, 2018USD ($)

Nov. 14, 2019CAD ($)

Sep. 14, 2021CAD ($)

May 14, 2020CAD ($)

Mar. 14, 2021CAD ($)

Jul. 31, 2022CAD ($)

Dec. 31, 2021USD ($)item$ / sharesshares

Dec. 31, 2021CAD ($)item

Dec. 31, 2020USD ($)

Dec. 31, 2020CAD ($)

Dec. 31, 2019USD ($)

Feb. 01, 2024USD ($)

Jul. 31, 2021CAD ($)

Oct. 31, 2019CAD ($)

Feb. 07, 2022$ / shares

Jan. 27, 2021USD ($)

Apr. 22, 2020CAD ($)

Apr. 10, 2019USD ($)

Debt Instrument [Line Items]

Gain on Extinguishment of Debt

$ 891,103

Accrued interest

$ 47,316

172,239

$ 47,316

Gain (loss) on settlement of debt

(668,260)

Interest expense

$ 267,966

286,896

BDC Term Loan [Member]

Debt Instrument [Line Items]

Maturity date

Oct. 15, 2021

Oct. 15, 2021

Principal payment

$ 80,000

$ 16,000

$ 8,500

$ 14,000

$ 10,000

$ 12,000

$ 88,000

Debt instrument interest rate

23.50%

ACOA Note [Member]

Debt Instrument [Line Items]

Maturity date

Feb. 1, 2024

Feb. 1, 2024

Principal payment

$ 45,052

$ 3,500

$ 3,000

Repayment of promissory note

$ 10,485

COVID payment deferral duration

9 months

9 months

ACOA Note [Member] | Forecast [Member]

Debt Instrument [Line Items]

Principal payment

$ 2,215

$ 4,000

$ 4,500

Wintrust Loan [Member]

Debt Instrument [Line Items]

Principal payment

$ 33,333

400,000

Proceeds from loan refinance

1,000,000

Debt instrument principal amount

$ 1,000,000

Debt instrument term

3 years

Wintrust Loan [Member] | Prime Rate [Member]

Debt Instrument [Line Items]

Basis spread on interest rate

1.50%

Chase Bank [Member]

Debt Instrument [Line Items]

Maturity date

Apr. 10, 2022

Apr. 10, 2022

Debt instrument principal amount

$ 891,103

Debt instrument term

2 years

2 years

Debt instrument interest rate

1.00%

Deferral period

6 months

6 months

Gain on Extinguishment of Debt

$ 891,103

TD Bank [Member]

Debt Instrument [Line Items]

Maturity date

Dec. 31, 2022

Dec. 31, 2022

Debt instrument principal amount

$ 40,000

Debt instrument interest rate

0.00%

Percent of loan forgiven

25.00%

25.00%

Percent of loan repaid requirement for forgiveness

75.00%

75.00%

Unsecured Promissory Notes [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 3,500,000

$ 1,080,000

$ 3,500,000

Debt instrument term

2 years

Debt instrument interest rate

15.00%

15.00%

15.00%

Note payable

$ 0

Commissions paid

$ 0

Debt instrument pre-payment penalty

2.00%

2.00%

2.00%

Repayment of related party debt

$ 1,000,000

Debt instrument conversion amount

$ 2,500,000

Debt instrument conversion, accrued interest

$ 82,916

Gain (loss) on settlement of debt

$ (232,462)

Unsecured Promissory Notes 3 [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 200,000

Debt instrument term

2 years

Debt instrument interest rate

15.00%

Debt instrument pre-payment penalty

2.00%

Unsecured Promissory Notes 4 [Member]

Debt Instrument [Line Items]

Number of notes issued | item

2

Debt instrument principal amount

$ 500,000

Debt instrument term

2 years

Debt instrument interest rate

15.00%

Debt instrument pre-payment penalty

2.00%

Unsecured Promissory Notes 5 [Member]

Debt Instrument [Line Items]

Principal balance outstanding

580,000

580,000

Accrued interest

42,492

42,492

Gain (loss) on settlement of debt

$ (668,260)

Unsecured Promissory Notes 5 [Member] | Principal [Member]

Debt Instrument [Line Items]

Debt instrument conversion amount

1,200,000

Unsecured Promissory Notes 5 [Member] | Accrued Interest [Member]

Debt Instrument [Line Items]

Debt instrument conversion amount

$ 192,208

Subsequent Event [Member]

Debt Instrument [Line Items]

Warrant exercise price | $ / shares

$ 0.80

Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 271,875

Debt instrument interest rate

15.00%

Warrants issued | shares

33,017

Debt instrument pre-payment penalty

2.00%

Accrued interest

$ 34,379

Director [Member] | Credit Agreement [Member]

Debt Instrument [Line Items]

Maturity date

Jun. 30, 2024

Jun. 30, 2024

Debt instrument interest rate

15.00%

Maximum borrowing capacity

$ 3,500,000

Repayment of line of credit

$ 200,000

Amount outstanding

3,478,125

Amount drawn from facility

3,206,250

Principal and accrued interest

271,875

Accrued interest

$ 149,040

Number of monthly installments | item

24

24

Warrants to purchase common stock | shares

600,570

Warrant exercise price | $ / shares

$ 1.67

Warrant exercisable period, after issuance of financing

36 months

36 months

Fair value of warrants

$ 262,758

Credit facility fee, numerator

20.00%

20.00%

Credit facility fee, denominator measurement period

30 days

30 days

Warrant vesting period

3 years

3 years

Fair value of warrants issued

$ 262,758

Notes Payable and Interest Ex_4

Notes Payable and Interest Expense (Schedule of Notes Payable) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Total Debt	$ 3,426,380	$ 2,140,677
Less current portion	(888,583)	(641,676)
Long-term debt, net of current portion	$ 2,537,797	1,499,001
BDC Term Loan [Member]
Debt Instrument [Line Items]
Maturity	Oct. 15, 2021
Interest Rate	23.50%
Total Debt		160,088
ACOA Note [Member]
Debt Instrument [Line Items]
Maturity	Feb. 1, 2024
Total Debt	$ 76,642	111,430
Wintrust Bank [Member]
Debt Instrument [Line Items]
Maturity	Nov. 1, 2021
Basis spread on interest rate	1.50%
Total Debt		366,666
TD Bank [Member]
Debt Instrument [Line Items]
Maturity	Dec. 31, 2022
Interest Rate	0.00%
Total Debt	$ 31,496	31,390
Chase Bank [Member]
Debt Instrument [Line Items]
Maturity	Apr. 10, 2022
Interest Rate	1.00%
Total Debt		891,103
Related Party Note [Member]
Debt Instrument [Line Items]
Interest Rate	15.00%
Total Debt	$ 3,318,242	$ 580,000

Notes Payable and Interest Ex_5

Notes Payable and Interest Expense (Schedule of Principal Payments on Notes Payable) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Notes Payable and Interest Expense [Abstract]
2022	$ 1,106,676
2023	1,808,523
2024	447,231
2025	63,950
2026
Thereafter
Total Debt	$ 3,426,380	$ 2,140,677

Notes Payable and Interest Ex_6

Notes Payable and Interest Expense (Summary of Interest Expense) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Notes Payable and Interest Expense [Abstract]
Interest expense	$ 267,966	$ 286,896
Total interest expense	$ 267,966	$ 286,896

Common Stock and Equity Payab_2

Common Stock and Equity Payable (Details)	Sep. 17, 2020$ / sharesshares	Mar. 02, 2020$ / sharesshares	Dec. 31, 2020USD ($)item$ / shares	Dec. 31, 2021USD ($)shares	Dec. 31, 2020USD ($)shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Shares issued | shares	15,000	234,500		0	1,113,767
Strike price per share | $ / shares	$ 0.48	$ 1
Ratio of converted warrant units | item			1
Sale of common stock | shares					2,666,459
Proceeds from sale of common stock					$ 3,333,074
Loss on conversion					(668,260)
Equity payable			$ 100,862		100,862
Warrant Issuance [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price | $ / shares			$ 1.25
New Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price | $ / shares			$ 2
Restricted Stock Units RSU [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Stock-based compensation expense				$ 447,506	260,003
Restricted Stock Units RSU [Member] | Board of Directors [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Stock-based compensation expense				260,005	260,003
Restricted Stock Units RSU [Member] | Employees [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Stock-based compensation expense				$ 187,501
Principal [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Face amount					1,200,000
Accrued Interest [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Face amount					$ 192,208

Stock-based Plans and Stock-b_3

Stock-based Plans and Stock-based Compensation (Narrative) (Details)	Dec. 15, 2021USD ($)employee$ / sharesshares	Aug. 11, 2021USD ($)employee$ / sharesshares	May 17, 2021USD ($)employee$ / sharesshares	May 12, 2021USD ($)employee$ / sharesshares	Mar. 26, 2021USD ($)employee$ / sharesshares	Feb. 23, 2021	Dec. 17, 2020USD ($)employee$ / sharesshares	Dec. 07, 2020USD ($)employee$ / sharesshares	Nov. 05, 2020USD ($)employee$ / sharesshares	Aug. 07, 2020USD ($)$ / sharesshares	Apr. 06, 2020USD ($)employee$ / sharesshares	Mar. 24, 2020USD ($)employee$ / sharesshares	Dec. 31, 2021USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized under stock plan													6,246,466
Shares available for future grants													30,263,320
Options to purchase shares, in-the-money													1,692,332
Weighted average grant date fair value | $ / shares													$ 0.99	$ 0.79
Number Of Employees, Awards Granted | employee	19	1	1		5		6	1	1		4	1
Options granted	545,000	5,000	20,000		67,500		210,000	600,000	20,000		700,000	15,000
Weighted average grant date fair value | $ / shares	$ 1.53	$ 1.53	$ 1.67		$ 1.80		$ 1.83	$ 1.55	$ 0.96		$ 0.70	$ 0.65
Monthly installments in which options vest, after initial vesting Anniversary	48 months	48 months	48 months		48 months		36 months	36 months	36 months			36 months
Volatility rate	71.53%	73.29%	74.79%		73.97%		77.41%	77.35%	77.36%		78.21%	77.56%
Call option value, price per share | $ / shares	$ 0.97	$ 1.12	$ 0.93		$ 1.16		$ 1.21	$ 1.03	$ 0.63		$ 0.47	$ 0.43
Call option value | $	$ 528,434	$ 5,606	$ 18,628		$ 78,492		$ 254,373	$ 615,495	$ 12,689		$ 326,752	$ 6,472
Unearned stock based compensation expense | $													$ 1,527,647
First Anniversary [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rate							25.00%	25.00%	25.00%		25.00%	25.00%
Thirty-Six Months [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted											500,000
Monthly installments in which options vest, after initial vesting Anniversary											36 months
Forty-Eight Months [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted											200,000
Monthly installments in which options vest, after initial vesting Anniversary											48 months
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual terms (period)													10 years
Options granted													637,500	1,545,000
Vesting period													4 years
Restricted Stock Units RSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number Of Employees, Awards Granted | employee	4	4		4
Units issued	42,484	37,144		38,924			35,520		67,708	81,252		100,000	654,663	284,480
Value of units | $	$ 65,000	$ 65,000		$ 65,000			$ 65,000		$ 65,000	$ 65,000		$ 65,000
Value of units, per share | $ / shares	$ 1.53	$ 1.75		$ 1.67			$ 1.83		$ 0.96	$ 0.80		$ 0.65	$ 1.77	$ 0.91
Vesting period						4 years
Board compensation | $													$ 447,506	$ 260,003
Four Independent Directors [Member] | Restricted Stock Units RSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number Of Employees, Awards Granted | employee					4
Units issued					36,112
Value of units | $					$ 65,000
Value of units, per share | $ / shares					$ 1.80
Employees [Member] | Restricted Stock Units RSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Units issued					500,000
Value of units | $					$ 900,000
Value of units, per share | $ / shares					$ 1.80
Vested in period					114,583
Employees [Member] | Restricted Stock Units RSU [Member] | Forty-Eight Months [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rate					2.08%

Stock-based Plans and Stock-b_4

Stock-based Plans and Stock-based Compensation (Stock Option Activity) (Details) - USD ($)	Dec. 15, 2021	Aug. 11, 2021	May 17, 2021	Mar. 26, 2021	Dec. 17, 2020	Dec. 07, 2020	Nov. 05, 2020	Apr. 06, 2020	Mar. 24, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Granted	545,000	5,000	20,000	67,500	210,000	600,000	20,000	700,000	15,000
Employee Stock Option [Member]
Outstanding at Beginning of Period										6,007,552	5,781,884
Granted										637,500	1,545,000
Exercised											(15,000)
Forfeit/canceled										(272,029)	(814,068)
Expired										(126,557)	(490,264)
Outstanding at End of Period										6,246,466	6,007,552	5,781,884
Expected to vest at End of Period										6,246,466
Exercisable at End of Period										4,063,765
Unrecognized expense at End of Period										$ 1,527,647
Weighted Average Exercise Price Per Share
Outstanding at Beginning of Period										$ 1.20	$ 1.15
Granted										1.56	1.19
Exercised										1.61	0.48
Forfeit/canceled										2.18	0.94
Expired										1.17	1.07
Outstanding at End of Period										1.20	$ 1.20	$ 1.15
Vested										1.20
Exercisable at end of period										$ 1.17
Weighted Average Remaining Contractual Life (Years)
Outstanding, Weighted Average Remaining Contractual Term (Years)										7 years 2 months 1 day	6 years 9 months 7 days	7 years 1 month 28 days
Expected, Weighted Average Remaining Contractual Term (Years)										6 years 1 month 20 days
Exercisable, Weighted Average Remaining Contractual Term (Years)										4 years 10 months 2 days
Aggregate Intrinsic Value
Aggregate Intrinsic Value, Outstanding										$ 2,500,847	$ 4,056,639	$ 527,868
Expected to vest at End of Period										4,056,639
Exercisable at End of Period										$ 2,252,766

Stock-based Plans and Stock-b_5

Stock-based Plans and Stock-based Compensation (Stock Based Compensation Expense - Stock Options and Warrants) (Details) - Employee Stock Option [Member] - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 549,768	$ 513,935
General and Administrative [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	289,782	267,306
Sales and Marketing [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	81,093	75,235
Engineering, Research and Development [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 178,893	$ 171,394

Stock-based Plans and Stock-b_6

Stock-based Plans and Stock-based Compensation (Valuation Assumptions) (Details)	Dec. 15, 2021	Aug. 11, 2021	May 17, 2021	Mar. 26, 2021	Dec. 17, 2020	Dec. 07, 2020	Nov. 05, 2020	Apr. 06, 2020	Mar. 24, 2020	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life (years)										6 years	6 years
Expected dividend yield										0.00%	0.00%
Expected volatility	71.53%	73.29%	74.79%	73.97%	77.41%	77.35%	77.36%	78.21%	77.56%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate										0.42%	0.42%
Expected volatility										59.90%	77.36%
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate										0.58%	0.58%
Expected volatility										80.26%	78.21%

Stock-based Plans and Stock-b_7

Stock-based Plans and Stock-based Compensation (Restricted Stock Unit Activity) (Details) - USD ($)	Dec. 15, 2021	Aug. 11, 2021	May 12, 2021	Dec. 17, 2020	Nov. 05, 2020	Aug. 07, 2020	Mar. 24, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Released, Shares
Canceled/forfeited/expired, Shares
Unvested at end of period
Unrecognized expense at end
Exercised, Weighted Average Exercise Price
Restricted Stock Units RSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at Beginning of Period								1,436,728	1,152,248
Awarded, Shares	42,484	37,144	38,924	35,520	67,708	81,252	100,000	654,663	284,480
Canceled/forfeited/expired, Shares								(406,250)
Outstanding at End of Period								1,685,141	1,436,728	1,152,248
Vested at end of period								1,685,141
Outstanding at beginning of period, Weighted Average Exercise Price								$ 0.86	$ 0.86
Forfeited, Weighted Average Exercise Price								2
Outstanding at end of period, Weighted Average Exercise Price								$ 1.18	$ 0.86	$ 0.86
Awarded, Aggregate Intrinsic Value								$ 260,005	$ 60,003
Outstanding, aggregate intrinsic value								1,248,073	$ 1,180,407	$ 1,120,404
Canceled/forfeited/expired, aggregate intrinsic value								(192,339)
Vested, aggregate intrinsic value								$ 2,595,117

Stock-based Plans and Stock-b_8

Stock-based Plans and Stock-based Compensation (Stock Based Compensation Expense - Restricted Stock) (Details) - Restricted Stock Units RSU [Member] - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 447,506	$ 260,003
General and Administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	260,005	$ 260,003
Sales and Marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 187,501

Warrants to Purchase Common S_3

Warrants to Purchase Common Stock (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Investor Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award exercised		2,900,959
Warrant Issuance [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award exercised	0
Stock-based compensation expense	$ 0	$ 0

Warrants to Purchase Common S_4

Warrants to Purchase Common Stock (Summary of Investor Warrant Activity) (Details) - $ / shares	Dec. 15, 2021	Aug. 11, 2021	May 17, 2021	Mar. 26, 2021	Dec. 17, 2020	Dec. 07, 2020	Nov. 05, 2020	Apr. 06, 2020	Mar. 24, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted	545,000	5,000	20,000	67,500	210,000	600,000	20,000	700,000	15,000
Share-Based Compensation Arrangement By Share-Based Payment Award Equity Instruments Other Than Options Exercise In Period Weighted Average Exercise Price
Investor Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at Beginning of Period										2,691,459	3,358,459
Granted										580,231	2,666,459
Exercised											(2,900,959)
Canceled/forfeited/expired										(25,000)	(432,500)
Outstanding at End of Period										3,246,690	2,691,459	3,358,459
Outstanding at beginning of period, Weighted Average Exercise Price										$ 1.99	$ 1.23
Awarded, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement By Share-Based Payment Award Equity Instruments Other Than Options Exercise In Period Weighted Average Exercise Price
Cancelled/forfeited/expired, Weighted Average Exercise Price
Outstanding at end of period, Weighted Average Exercise Price										$ 2.26	$ 1.99	$ 1.23
Outstanding, Weighted Average Remaining Contractual Term (Years)										3 years 7 months 2 days	2 years 11 months 8 days	1 year 3 months 7 days

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating Loss Carryforwards [Line Items]
Change in valuation allowance	$ 2,479,000	$ 568,000
Change in ownership limit, operating loss	207,000
Pre change net operating loss carryforward	6,000,000
Liability for uncertain tax positions	0
Accrued interest and penalties	0
State And Local Jurisdiction [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	61,000,000
State And Local Jurisdiction [Member] | Earliest Tax Year [Member]
Operating Loss Carryforwards [Line Items]
Tax years subject to examination		2006
Domestic Country [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 64,000,000
Domestic Country [Member] | Earliest Tax Year [Member]
Operating Loss Carryforwards [Line Items]
Tax years subject to examination		2006

Income Taxes (Provisions for In

Income Taxes (Provisions for Income Taxes) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Taxes [Abstract]
Federal - current	$ 0	$ 0
State - current	0	0
Foreign- current	0	0
Total	$ 0	$ 0

Income Taxes (Net Deferred Tax

Income Taxes (Net Deferred Tax Assets and Liabilities) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets (liabilities):
Net operating loss carryforwards	$ 16,915,000	$ 14,881,000
Stock based compensation	4,372,000	4,094,000
Accrued compensation	31,000	19,000
Depreciation and amortization	3,783,000	3,867,000
Other	2,000
Total deferred tax assets	25,103,000	22,861,000
Valuation allowance for net deferred tax assets	(25,103,000)	(22,861,000)
Total

Income Taxes (Difference Betwee

Income Taxes (Difference Between Provision for Income Taxes and Income Taxes Computed Using Federal Income Tax Rate) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Taxes [Abstract]
Computed expected tax expense	$ (1,735,000)	$ (613,000)
State taxes, net of federal benefit	(799,000)	(141,000)
Expiration of NOL carryforwards	87,000	44,000
Other	(32,000)	142,000
Change in valuation allowance	2,479,000	568,000
Total

Fair Value Measurements of Fi_3

Fair Value Measurements of Financial Instruments (Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Fair Value Measurements Recurring [Member] | Fair Value Inputs Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill
Intangibles, net
Fair Value Measurements Recurring [Member] | Fair Value Inputs Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill
Intangibles, net
Fair Value Measurements Recurring [Member] | Fair Value Inputs Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill	411,183	496,352
Intangibles, net	1,124,720	1,368,329
Goodwill [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) from fair value measurement
Intangibles, Net [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) from fair value measurement

Commitments and Contingencies (

Commitments and Contingencies (Narrative) (Details)	1 Months Ended	12 Months Ended
	Feb. 28, 2021USD ($)ft²	Jan. 31, 2022	Dec. 31, 2021USD ($)ft²
Commitments And Contingencies [Line Items]
Operating lease asset			$ 1,187,537
Operating lease liability			$ 1,417,829
Lease Ending January 2021 [Member] | Arizona [Member]
Commitments And Contingencies [Line Items]
Area of property | ft²			10,395
Monthly rental expense			$ 20,140
Operating lease asset			0
Operating lease liability			0
Lease Starting February 2021 [Member] | Arizona [Member]
Commitments And Contingencies [Line Items]
Area of property | ft²	8,898
Operating lease asset			1,177,094
Operating lease liability			1,404,533
Lease Starting February 2021 [Member] | Arizona [Member] | Subsequent Event [Member]
Commitments And Contingencies [Line Items]
Lease abatement percentage		50.00%
Lease Starting February 2021 [Member] | Arizona [Member] | Minimum [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense	$ 25,953
Lease Starting February 2021 [Member] | Arizona [Member] | Maximum [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense	$ 28,733
Lease Ending April 2022 [Member] | Halifax, Nova Scotia [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense			$ 3,371
Lease area of office | ft²			3,248
Operating lease asset			$ 10,443
Operating lease liability			$ 13,296
Forecast [Member] | Lease Starting February 2021 [Member] | Arizona [Member]
Commitments And Contingencies [Line Items]
Lease abatement percentage		50.00%

Employee Benefit Plan (Details)

Employee Benefit Plan (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Employee Benefit Plan [Abstract]
Contributions to the Plan	$ 0	$ 0

Related Party Transactions (Nar

Related Party Transactions (Narrative) (Details)	Jul. 01, 2021USD ($)	Jan. 27, 2021USD ($)	Jan. 25, 2021USD ($)	Dec. 31, 2020USD ($)	Nov. 18, 2020USD ($)	Feb. 26, 2020USD ($)	Jul. 02, 2019USD ($)	Nov. 30, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Jul. 31, 2019USD ($)shares	Feb. 28, 2018USD ($)	Jun. 30, 2021USD ($)shares	Dec. 31, 2021USD ($)item$ / sharesshares	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Related Party Transaction [Line Items]
Due from Related Parties				$ 1,080,000					$ 1,080,000						$ 1,080,000
Accrued interest				47,316					47,316					$ 172,239	47,316
Loss on settlement of debt															668,260
Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt instrument principal amount										$ 3,500,000		$ 1,080,000				$ 3,500,000
Debt instrument term										2 years
Debt instrument pre-payment penalty										2.00%				2.00%
Debt instrument conversion amount							$ 2,500,000
Debt instrument conversion, accrued interest							$ 82,916
Due from Related Parties										$ 80,000						80,000
Commissions paid												$ 0
Loss on settlement of debt																232,462
Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt instrument interest rate										15.00%
Aggregate principal amount settled									1,000,000
Amount of debt repaid									1,000,000
Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt instrument principal amount	$ 271,875
Debt instrument pre-payment penalty	2.00%
Accrued interest		$ 34,379
Aggregate principal amount settled		15,000	$ 65,000
Amount of debt repaid		$ 15,000	$ 65,000
Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt instrument principal amount					$ 500,000	$ 200,000
Debt instrument principal amount													$ 271,875
Debt instrument term					2 years	2 years
Debt instrument interest rate					15.00%	15.00%							15.00%
Debt instrument pre-payment penalty					2.00%	2.00%							2.00%
Debt instrument conversion amount				1,200,000
Debt instrument conversion, accrued interest				192,208
Related party note				580,000					580,000						580,000
Accrued interest				42,492					42,492						$ 42,492
Loss on settlement of debt				668,260
Warrants issued | shares													33,017
Director [Member] | Credit Agreement [Member]
Related Party Transaction [Line Items]
Debt instrument interest rate														15.00%
Maximum borrowing capacity														$ 3,500,000
Repayment of line of credit								$ 200,000
Amount outstanding														3,478,125
Amount drawn from facility														3,206,250
Principal and accrued interest														$ 271,875
Number of monthly installments | item														24
Accrued interest														$ 149,040
Warrants issued | shares														600,570
Warrants to purchase common stock | shares														600,570
Warrant exercisable period, after issuance of financing														36 months
Warrant exercise price | $ / shares														$ 1.67
Fair value of warrants														$ 262,758
Warrant vesting period														3 years
Credit facility fee, numerator														20.00%
Credit facility fee, denominator measurement period														30 days
Director [Member] | Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt instrument principal amount																$ 3,500,000
Debt instrument term																2 years
Debt instrument interest rate																15.00%
Debt instrument pre-payment penalty															2.00%
Debt instrument conversion amount											$ 2,500,000
Debt instrument conversion, accrued interest											$ 82,916
Debt converted into shares | shares											2,582,916
Related party note				80,000					80,000						$ 80,000
Accrued interest				$ 33,533					$ 33,533						$ 33,533

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details) - Subsequent Event [Member]	Feb. 07, 2022USD ($)$ / sharesshares
Subsequent Event [Line Items]
Number of warrants exercised | shares	3,163,190
Warrants outstanding, per share | $ / shares	$ 0.80
Warrants Issued, Number Of Shares Of Stock | shares	2,530,552
Additional capital | $	$ 2,530,552
Common stock price | $ / shares	$ 1.50
Warrant Issuance [Member]
Subsequent Event [Line Items]
Warrant term	3 years